背景:厌氧覆盖范围扩大的抗生素通常用于治疗吸入性肺炎,这是不建议由当前的指导方针。
目的:因社区获得吸入性肺炎入院的患者,在住院死亡率和艰难梭菌结肠炎的风险方面,有限厌氧覆盖率的抗生素治疗(LAC)与延长厌氧覆盖率的抗生素治疗(EAC)之间是否存在差异?
方法:我们在安大略省的18家医院进行了一项多中心回顾性队列研究,加拿大从2015年1月1日至2022年1月1日。如果医生诊断患者患有吸入性肺炎,并在入院后48小时内规定了符合指南的一线社区获得性肺炎肠外抗生素治疗,则将患者包括在内。然后将患者分为LAC组,如果他们接受头孢曲松,头孢噻肟或左氧氟沙星。如果患者接受阿莫西林-克拉维酸,则属于EAC组,莫西沙星,或者任何头孢曲松,头孢噻肟,或左氧氟沙星与克林霉素或甲硝唑联合使用。主要结果是医院的全因死亡率。次要结果包括入院后发生的艰难梭菌结肠炎。倾向评分的重叠加权用于平衡基线预后因素。
结果:LAC组和EAC组分别为2,683例和1,316例。在医院,LAC和EAC组分别有814例(30.3%)和422例(32.1%)患者死亡。在LAC和EAC组中,艰难梭菌结肠炎分别发生在5例或更少(≤0.2%)和11至15例(0.8%至1.1%)患者中。在倾向得分重叠加权后,EAC减去LAC的校正风险差异对于住院死亡率为1.6%(95%CI-1.7%~4.9%),对于艰难梭菌结肠炎为1.0%(95%CI0.3%~1.7%).
结论:吸入性肺炎可能没有必要扩大无氧覆盖范围,因为它没有额外的死亡率获益。只有艰难梭菌结肠炎的风险增加。
BACKGROUND: Antibiotics with extended anaerobic coverage are used commonly to treat aspiration pneumonia, which is not recommended by current guidelines.
OBJECTIVE: In patients admitted to hospital for community-acquired aspiration pneumonia, does a difference exist between antibiotic therapy with limited anaerobic coverage (LAC) vs antibiotic therapy with extended anaerobic coverage (EAC) in terms of in-hospital mortality and risk of Clostridioides difficile colitis?
METHODS: We conducted a multicenter retrospective cohort
study across 18 hospitals in Ontario, Canada, from January 1, 2015, to January 1, 2022. Patients were included if the physician diagnosed aspiration pneumonia and prescribed guideline-concordant first-line community-acquired pneumonia parenteral antibiotic therapy to the patient within 48 h of admission. Patients then were categorized into the LAC group if they received ceftriaxone, cefotaxime, or levofloxacin. Patients were categorized into the EAC group if they received amoxicillin-clavulanate, moxifloxacin, or any of ceftriaxone, cefotaxime, or levofloxacin in combination with clindamycin or metronidazole. The primary outcome was all-cause in-hospital mortality. Secondary outcomes included incident C difficile colitis occurring after admission. Overlap weighting of propensity scores was used to balance baseline prognostic factors.
RESULTS: The LAC and EAC groups included 2,683 and 1,316 patients, respectively. In hospital, 814 patients (30.3%) and 422 patients (32.1%) in the LAC and EAC groups died, respectively. C difficile colitis occurred in five or fewer patients (≤ 0.2%) and 11 to 15 patients (0.8%-1.1%) in the LAC and EAC groups, respectively. After overlap weighting of propensity scores, the adjusted risk difference of EAC minus LAC was 1.6% (95% CI, -1.7% to 4.9%) for in-hospital mortality and 1.0% (95% CI, 0.3%-1.7%) for C difficile colitis.
CONCLUSIONS: We found that extended anaerobic coverage likely is unnecessary in aspiration pneumonia because it was associated with no additional mortality benefit, only an increased risk of C difficile colitis.